# A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of Pregnancy

> **NCT00996580** · PHASE3 · COMPLETED · sponsor: **Teva Women's Health** · enrollment: 3597 (actual)

## Conditions studied

- Pregnancy Prevention

## Interventions

- **DRUG:** DR-103

## Key facts

- **NCT ID:** NCT00996580
- **Lead sponsor:** Teva Women's Health
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 3597 (ACTUAL)
- **Last updated:** 2013-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00996580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00996580, "A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of Pregnancy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00996580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*